Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Chenguang Biotech Group Co Ltd
SZSE:300138

Watchlist Manager
Chenguang Biotech Group Co Ltd Logo
Chenguang Biotech Group Co Ltd
SZSE:300138
Watchlist
Price: 13.54 CNY -1.88% Market Closed
Market Cap: ¥6.5B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Chenguang Biotech Group Co Ltd

Wall Street analysts forecast Chenguang Biotech Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chenguang Biotech Group Co Ltd is 18.24 CNY with a low forecast of 17.94 CNY and a high forecast of 18.9 CNY.

Lowest Forecast
Wall Street Target
17.94 CNY
32% Upside
Average Forecast
Wall Street Target
18.24 CNY
35% Upside
Highest Forecast
Wall Street Target
18.9 CNY
40% Upside
Lowest
Price Target
17.94 CNY
32% Upside
Average
Price Target
18.24 CNY
35% Upside
Highest
Price Target
18.9 CNY
40% Upside
Chenguang Biotech Group Co Ltd Competitors:
Price Targets
CWCO
Consolidated Water Co Ltd
19% Upside
CWCO
Consolidated Water Co Ltd
19% Upside

Revenue
Forecast

16% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
16% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 8%.

What are analyst estimates?

Operating Income
Forecast

5% / Year
Past Growth
69% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
5% / Year
Past Growth
69% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

For the last 13 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's operating income is 5%. The projected CAGR for the next 3 years is 69%.

What are analyst estimates?

Net Income
Forecast

2% / Year
Past Growth
86% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
2% / Year
Past Growth
86% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 13 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 86%.

What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Chenguang Biotech Group Co Ltd's stock price target?
Price Target
18.24 CNY

According to Wall Street analysts, the average 1-year price target for Chenguang Biotech Group Co Ltd is 18.24 CNY with a low forecast of 17.94 CNY and a high forecast of 18.9 CNY.

What is Chenguang Biotech Group Co Ltd's Revenue forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 8%.

What is Chenguang Biotech Group Co Ltd's Operating Income forecast?
Projected CAGR
69%

For the last 13 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's operating income is 5%. The projected CAGR for the next 3 years is 69%.

What is Chenguang Biotech Group Co Ltd's Net Income forecast?
Projected CAGR
86%

For the last 13 years the compound annual growth rate for Chenguang Biotech Group Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 86%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.